Search Results - "Roagna, R."

Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Long term results of the Italian Tamoxifen Anastrozole trial by Boccardo, F, Guglielmini, P, Bordonaro, R, Fini, A, Massidda, B, Porpiglia, M, Roagna, R, Serra, P, Orzalesi, L, Ucci, G, Rubagotti, A

“…Abstract The Italian Tamoxifen Anastrozole (ITA) trial investigated the efficacy of switching to anastrozole for women who were already on adjuvant tamoxifen…”
Get full text

Evaluation of low-dose venlafaxine hydrochloride for the therapy of hot flushes in breast cancer survivors by Biglia, N., Torta, Riccardo, Roagna, R., Maggiorotto, F., Cacciari, F., Ponzone, R., Kubatzki, F., Sismondi, P.

“…: To evaluate the efficacy and tolerability of long-term treatment with venlafaxine at low dose for the reduction of vasomotor symptoms in breast cancer…”
Get full text

Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis by YOUSEF, G. M, BORGONO, C. A, SCORILAS, A, PONZONE, R, BIGLIA, N, ISKANDER, L, POLYMERIS, M.-E, ROAGNA, R, SISMONDI, P, DIAMANDIS, E. P

“…KLK14 (formerly known as KLK-L6) is a recently identified member of the human kallikrein gene family. This family harbours several genes aberrantly expressed…”
Get full text

Molecular forms of prostate-specific antigen in the serum of women with benign and malignant breast diseases by BORCHERT, G. H, MELEGOS, D. N, TOMLINSON, G, GIAI, M, ROAGNA, R, PONZONE, R, SGRO, L, DIAMANDIS, E. P

“…Using a highly sensitive immunofluorometric procedure, we measured the total prostate-specific antigen (PSA) concentration in 632 sera obtained from female…”
Get full text

Prognostic and predictive relevance of c-erbB-2 and ras expression in node positive and negative breast cancer by Giai, M, Roagna, R, Ponzone, R, De Bortoli, M, Dati, C, Sismondi, P

“…The protein product of c-erbB-2 and ras oncogene has been examined for its prognostic potential in both node positive and node negative breast cancer. Using a…”
Get more information

How to manage the menopause following therapy for breast cancer. Is raloxifene a safe alternative? by Sismondi, P, Biglia, N, Roagna, R, Ponzone, R, Ambroggio, S, Sgro, L, Cozzarella, M

“…Raloxifene is a selective oestrogen receptor modulator (SERM) that has anti-oestrogenic effects on breast and endometrial tissue and oestrogenic actions on…”
Get full text

Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients by ZARGHAMI, N, GIAI, M, YU, H, ROAGNA, R, PONZONE, R, KATSAROS, D, SISMONDI, P, DIAMANDIS, E. P

“…Creatinine kinase BB (CK-BB) is elevated in many tumours including those of the breast. We have recently described a new, highly sensitive and specific method…”
Get full text

Prostate-specific antigen in serum of women with breast cancer by GIAI, M, YU, H, ROAGNA, R, PONZONE, R, KATSAROS, D, LEVESQUE, M. A, DIAMANDIS, E. P

“…Prostate-specific antigen (PSA) was recently found in 30% of female breast tumours. In this study we have examined if PSA circulates in the blood of breast…”
Get full text

Sentinel node biopsy for breast cancer: yes, less surgery is better surgery by Sismondi, P, Ponzone, R, Biglia, N, Roagna, R, Cacciari, F, Maggiorotto, F

“…Breast surgery evolves towards always more precise, but less invasive techniques. The halstedian concept of radical surgery has been abandoned and the majority…”
Get more information

Raloxifene and endometrial cancer by Sismondi, P, Biglia, N, Ujcic, E, Ponzone, R, Roagna, R

Get full text

Sentinel lymph node and breast cancer staging: final results of the Turin Multicenter Study by Casalegno, P S, Sandrucci, S, Bellò, M, Durando, A, Danese, S, Silvestro, L, Pellerito, R, Testori, O, Roagna, R, Giai, M, Giani, R, Bussone, R, Favero, A, Bisi, G, Massobrio, M, Giardina, G, Mussa, G C, Sismondi, P, Mussa, A

“…Validation of the sentinel node (SN) technique in breast cancer by means of lymphoscintigraphy. From December 1996 to January 1999 102 T1-T2 breast carcinoma…”
Get full text

Menopause after breast cancer: a survey on breast cancer survivors by Biglia, Nicoletta, Cozzarella, Marilena, Cacciari, Franca, Ponzone, Riccardo, Roagna, Riccardo, Maggiorotto, Furio, Sismondi, Piero

“…Due to the younger age and the ever wider use of adjuvant chemotherapy and antiestrogens, menopausal symptoms are a frequent cause of concern for breast cancer…”
Get full text

Human Kallikrein Gene 5 (KLK5) Expression by Quantitative PCR: An Independent Indicator of Poor Prognosis in Breast Cancer by Yousef, George M, Scorilas, Andreas, Kyriakopoulou, Lianna G, Rendl, Laura, Diamandis, Maria, Ponzone, Riccardo, Biglia, Nicoletta, Giai, Maurizia, Roagna, Riccardo, Sismondi, Piero, Diamandis, Eleftherios P

“…KLK5 is a newly discovered human kallikrein gene. Many kallikrein genes have been found to be differentially expressed in various malignancies, and…”
Get full text

Hormone replacement therapy in cancer survivors by Biglia, Nicoletta, Gadducci, Angelo, Ponzone, Riccardo, Roagna, Riccardo, Sismondi, Piero

“…Objective: Thousands of women are treated each year for cancer; many of these are already in menopause, while other younger patients will go into early…”
Get full text

The prognostic value of the human kallikrein gene 9 (KLK9) in breast cancer by YOUSEF, George M, SCORILAS, Andreas, NAKAMURA, Terukazu, ELLATIF, Mohamed Abd, PONZONE, Riccardo, BIGLIA, Nicoletta, MAGGIOROTTO, Furio, ROAGNA, Riccardo, SISMONDI, Piero, DIAMANDIS, Eleftherios P

“…Many members of the human kallikrein gene family were found to be differentially expressed in various malignancies and some of them are useful…”
Get full text

Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer by HE YU, GIAI, M, DIAMANDIS, E. P, KATSAROS, D, SUTHERLAND, D. J. A, LEVESQUE, M. A, ROAGNA, R, PONZONE, R, SISMONDI, P

“…Prostate-specific antigen (PSA) is thought to be produced exclusively by prostatic epithelial cells and is currently used as a tumor marker of prostatic…”
Get full text

Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue by YU, H, DIAMANDIS, E. P, LEVESQUE, M, GIAI, M, ROAGNA, R, PONZONE, R, SISMONDI, P, MONNE, M, CROCE, C. M

“…Prostate specific antigen (PSA) is a tumor marker used widely for the diagnosis and monitoring of prostatic adenocarcinoma. Recently, we provided evidence that…”
Get full text

Immunoenzymatically Determined Pepsinogen C Concentration in Breast Tumor Cytosols: An Independent Favorable Prognostic Factor in Node-positive Patients by SCORILAS, A, DIAMANDIS, E. P, LEVESQUE, M. A, PAPANASTASIOU-DIAMANDI, A, KHOSRAVI, M. J, GIAI, M, PONZONE, R, ROAGNA, R, SISMONDI, P, LOPEZ-OTIN, C

“…The aim of this study was to determine the concentration and to evaluate the prognostic value of pepsinogen C (PepC) in breast cancer patients. PepC is an…”
Get full text

TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients by Giai, M, Roagna, R, Ponzone, R, Biglia, N, Sgro, L, Perona, M, Sismondi, P

“…Tissue Polypeptide-specific Antigen (TPS) and CA 15.3 are two of the most widely studied tumor markers in the serum of breast cancer patients. TPS is a tumor…”
Get more information

HRT, breast and endometrial cancers: strategies and intervention options by Sismondi, Piero, Biglia, Nicoletta, Giai, Maurizia, Ponzone, Riccardo, Roagna, Riccardo, Sgro, Luca, Campagnoli, Carlo

“…The demand for hormone replacement therapy (HRT) by women who enter the menopause is rapidly increasing in all developed countries. The concern that HRT may…”
Get full text